Michael M. Crowley

Michael Crowley, Ph.D., serves as an Adjunct Professor of Molecular Pharmaceutics and Drug Delivery in the College of Pharmacy at The University of Texas at Austin. He concurrently leads Theridian Technologies, LLC as President and co-founded Oticara, Inc., providing specialized consulting in pharmaceutical development and drug delivery systems.

His educational background includes:

• B.S. in Chemistry from the University of Missouri at St. Louis
• M.A. in Organic Chemistry from Washington University
• Ph.D. in Pharmaceutics from The University of Texas at Austin

Research focuses on physical pharmacy and novel drug delivery systems, with expertise in hot-melt extrusion, amorphous dispersions, polymer stability, pulmonary drug delivery, and dosage form characterization. He has authored peer-reviewed publications and contributed chapters to Remington: The Science and Practice of Pharmacy.

Scientific Awards: No specific awards, fellowships, or medals are documented in the source material.

Advising and Grants: The text provides no information regarding student mentorship or grant funding activities.

Dr. Crowley is a co-inventor on five patents and multiple patent applications. With over 30 years in the pharmaceutical industry, he previously held VP roles at PharmaForm and has executive experience at Monsanto, Warner-Jenkinson, and Mission Pharmacal. His companies specialize in regulatory consulting, product development, and drug delivery technology.